BNF for Children May 2023 Update

This update contains 3 significant changes, 4 dose changes, 1 new monograph, and 1 deleted monograph.

Significant Changes:

• Pholcodine-containing cough and cold medicines: withdrawal from UK market as a precautionary measure [MHRA/CHM advice] (see advice in Aromatic inhalations, cough preparations and systemic nasal decongestants).
•  Smallpox and mpox vaccine: updated guidance for immunisation.
• Smallpox vaccine: title changed to Smallpox and mpox vaccine.

Dose Changes:

• Atazanavir [update to dosing for HIV infection when used with low-dose ritonavir].
• Calcipotriol with betamethasone [update to dosing].
• Migalastat [update to include dosing in children from 12 years old].
• Ritonavir [update to dosing for HIV infection when used to increase the effect of atazanavir].

New Monograph:

• Volibris® [ambrisentan].

Deleted Monograph:

• Pholcodine.